GP-Act III Acquisition Corp.
Business
GP-Act III Acquisition Corp. is a blank check company formed to effect mergers, share exchanges, asset or share acquisitions, reorganizations or similar business combinations with one or more operating businesses. It conducts capital markets transactions, including an initial public offering that issues units comprised of Class A ordinary shares and warrants and a related private placement, and holds proceeds in a trust pending a business combination. Its activities center on deal sourcing, due diligence and transaction structuring supported by its management and co-sponsors. While it may pursue targets globally, it intends to focus on high-potential U.S.-based businesses and uses public market mechanisms, shareholder votes or tender offers and trust account proceeds to consummate transactions.
Summary from filing dated 2025-03-28
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 |
|---|---|---|---|---|
| General and administrative expenses | 551,918 | 564,973 | 14,041 | |
| Loss from operations | −551,918 | −564,973 | −14,041 | |
| Interest earned on marketable securities held in Trust Account | 12 | 9 | — | |
| Total other income | 12 | 9 | — | |
| Net income | 12 | 9 | −14,041 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 |
|---|---|---|---|---|---|
| Cash | 112,660 | 483,572 | 1,208 | — | |
| Due from Sponsor | 5,254 | — | — | — | |
| Prepaid expenses | 70,197 | 191,783 | 2,100 | — | |
| Total Current Assets | 188,111 | 675,355 | 3,308 | — | |
| Long-term prepaid insurance | — | 61,667 | — | — | |
| Marketable securities held in Trust Account | 309 | 297 | — | — | |
| Total Assets | 309 | 297 | 530,238 | — | |
| Accrued expenses | 233,299 | 231,605 | — | — | |
| Total Current Liabilities | 634,612 | 631,605 | 628,182 | — | |
| Deferred legal fee | 350,000 | 350,000 | — | — | |
| Deferred underwriting fee payable | 14 | 14 | — | — | |
| Total Liabilities | 15 | 15 | 628,182 | — | |
| Commitments and Contingencies (Note 6) | — | — | — | — | |
| Class A ordinary shares subject to possible redemption, 28,750,000 shares at redemption value of $10.75 and $10.32 per share as of December 31, 2025 and 2024, respectively | 309 | 297 | — | — | |
| Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding as of December 31, 2025 and 2024 | — | — | — | — | |
| Additional paid-in capital | — | — | 24,281 | — | |
| Accumulated deficit | −14 | −14 | −122,944 | — | |
| Total Shareholders Deficit | −14 | −14 | −97,944 | −83,903 | |
| Total Liabilities, Class A ordinary shares subject to Possible Redemption, and Shareholders Deficit | 309 | 297 | 530,238 | — |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 |
|---|---|---|---|---|
| Prepaid expenses and other current assets | 121,586 | −189,683 | 2,000 | |
| Due from Sponsor | −5,254 | — | — | |
| Long-term prepaid insurance | 61,667 | −61,667 | — | |
| Accrued expenses | 1,694 | 231,605 | — | |
| Net cash used in operating activities | −372,225 | −584,718 | −10,970 | |
| Investment of cash into Trust Account | — | −288 | — | |
| Net cash used in investing activities | — | −288 | — | |
| Proceeds from sale of Units, net of underwriting discounts paid | — | 283 | — | |
| Proceeds from sale of Private Placements Warrants | — | 7 | — | |
| Proceeds from promissory note - related party | — | 200,000 | 10,420 | |
| Advances from related party | 1,313 | — | — | |
| Repayment of promissory note - related party | — | −428,182 | — | |
| Payment of offering costs | — | −704,736 | — | |
| Net cash provided by financing activities | 1,313 | 289 | 10,420 | |
| Net Change in Cash | −370,912 | 482,364 | −550 | |
| Deferred underwriting fee payable | — | 14 | — | |
| Deferred legal fees | — | 350,000 | — | |
| Deferred costs charged to APIC | — | 2 | — |